MEIOC prevents continued mitotic cycling and promotes meiotic entry during mouse oogenesis
Development · 2026
DOI: 10.1242/dev.205037 ↗At a glance
Journal article in Development, 2026. Written by Esther G Ushuhuda and 5 co-authors. Institution: Reproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Major MEDLINE topics: Meiosis, Oogenesis, Mitosis. Cited 4 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institute of Child Health and Human Development, NIH HHS, University of Cincinnati.
Abstract (original language)
To generate haploid gametes, germ cells must transition from mitosis to meiosis. In mammals, the transcriptional activator STRA8-MEIOSIN mediates the decision to enter the meiotic cell cycle, but how germ cells prevent continued mitotic cycling before meiotic entry remains unclear. MEIOC was previously shown to repress the mitotic program after meiotic entry. Here, we investigate the role of MEIOC in the mitosis-to-meiosis transition during mouse oogenesis. Using cell proliferation analysis and cell cycle transcriptomics, we demonstrate that MEIOC prevents continued mitotic cycling prior to meiotic entry in oogenic cells. We find that G1/S cyclin CCNA2 is downregulated during the mitosis-to-meiosis transition, and MEIOC contributes to this downregulation. MEIOC also promotes entry into meiosis by increasing Meiosin transcript abundance and consequently activating STRA8-MEIOSIN. Thus, in mouse oogenic cells, the transition from mitosis to meiosis occurs as two molecularly regulated steps – (1) the halt of mitotic cycling and (2) entry into the meiotic cell cycle – and that MEIOC modifies the cell cycle program to facilitate both steps in this transition.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Reproductive Sciences Center, Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Whitehead Institute, Cambridge, MA 02142, USA.
- Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
- Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
ORCID profiles: Shelbie M Wenner, Maria M Mikedis
Funding
- National Institute of Child Health and Human Development
- NIH HHS
- University of Cincinnati
- National Institutes of Health
Cite
APA
Ushuhuda, E. G., Nguyen, J. T., Pfaltzgraff, N. G., Wenner, S. M., Kofron, M., & Mikedis, M. M. (2026). MEIOC prevents continued mitotic cycling and promotes meiotic entry during mouse oogenesis. Development. https://doi.org/10.1242/dev.205037
Vancouver
Ushuhuda EG, Nguyen JT, Pfaltzgraff NG, Wenner SM, Kofron M, Mikedis MM. MEIOC prevents continued mitotic cycling and promotes meiotic entry during mouse oogenesis. Development. 2026. doi:10.1242/dev.205037
BibTeX
@article{Ushuhuda2026,
author = {Ushuhuda, Esther G and Nguyen, Jenniluyn T and Pfaltzgraff, Natalie G and Wenner, Shelbie M and Kofron, Matthew and Mikedis, Maria M},
title = {MEIOC prevents continued mitotic cycling and promotes meiotic entry during mouse oogenesis},
journal = {Development},
year = {2026},
doi = {10.1242/dev.205037}
}
EUVIMED